bosentan anhydrous has been researched along with Hepatitis B in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, L; Gao, F; Huang, S; Zhang, L; Zhao, S; Zhen, Y; Zhou, X | 1 |
| Descamps, D; Gervais, A; Larrouy, L; Le Beller, C; Lê, MP; Long, K; Mal, H; Papy, E; Peytavin, G | 1 |
2 other study(ies) available for bosentan anhydrous and Hepatitis B
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Benzamides; Drug Design; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Molecular Docking Simulation; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2019 |
Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
Topics: Antiviral Agents; Bosentan; Drug Interactions; Hepatitis B; Hepatitis C; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Oligopeptides; Sulfonamides | 2013 |